Helvetica Chimica Acta Vol. 85 (2002)
3613
General Procedure for the Synthesis of Racemic 12 and 14. Synthesis began from racemic leucine by first
protecting the amine functionality with a Boc group ((Boc)2O) [13], followed by DCC-mediated coupling to
diethylamide [14], deprotection with TFA [14] and finally acylation with one of the activated acids (analogously
to preparation of (Æ)-8). 4-Fluoro-3-nitrobenzoyl chloride was prepared similarly to 4-chloro-3,5-dinitroben-
zoyl chloride as in the preparation of 8 and used in the reaction without further purification.
4-Chloro-N-[1-(diethylcarbamoyl)-3-methylbutyl]-3,5-dinitrobenzamide ((Æ)-12) was obtained as a white
solid. M.p. 183 1868 . 1H-NMR (400 MHz, CDCl3):0.95 ( d, J 6.6, 3 H); 1.01 (d, J 6.6, 3 H); 1.14 (t, J 7.1,
3 H); 1.38 (t, J 7.1, 3 H); 1.41 (m, 1 H); 1.80 (m, 2 H); 3.18 (dq, J 13.8, 7.0, 1 H); 3.38 (dq, J 14.8, 7.4, 1 H);
3.48 (dq, J 15.0, 7.5, 1 H); 3.67 (dq, J 13.9, 7.0, 1 H); 5.09 (ddd, J 11.1, 8.1, 2.9, 1 H); 8.43 (s, 2 H). 13C-NMR
(100 MHz):12.7; 14.0; 21.2; 23.4; 24.9; 40.9; 41.0; 42.3; 49.3; 123.2; 126.3; 133.7; 149.2; 161.2; 172.5. FAB-MS:
415.1 ([M 1]1; calc. for M , 414.13). Anal. calc. for C17H23ClN4O6:C 49.22, H 5.59, N 13.51; found:C 49.05, H
5.52, 13.25.
N-[1-(Diethylcarbamoyl)-3-methylbutyl]-4-fluoro-3-nitrobenzamide ((Æ)-14) was obtained as a white
solid:57% yield. M.p. 109 110 8. 1H-NMR (400 MHz, CDCl3,):0.95 ( d, J 6.6, 3 H); 1.03 (d, J 6.6, 3 H); 1.15
(t, J 7.2, 3 H); 1.34 (t, J 7.2, 3 H); 1.42 (m, 1 H); 1.79 (m, 2 H); 3.23 (dq, J 13.8, 7.0); 3.41 (dq, J 14.7, 7.4);
3.47 (dq, J 14.7, 7.4); 3.63 (dq, J 13.8, 7.0); 5.11 (ddd, J 11.1, 8.1, 2.9); 7.25 (dd, J 10.1, 8.7, 1 H); 7.97
(d, J 8.1, 1 H); 8.05 (ddd, J 8.7, 4.2, 2.3, 1 H); 8.52 (dd, J 7.0, 2.3, 1 H). 13C-NMR (100 MHz, 408):13.1;
14.6; 21.9; 23.7; 25.2; 40.9; 42.3; 42.7; 48.8; 118.7 (d, J(C,F) 21.4); 125.6 (d, J(C,F) 1.5); 131.2 (d, J(C,F)
3.8); 134.4 (d, J(C,F) 9.2); 137.5 (d, J(C,F) 5.8); 157.3 (d, J(C,F) 270.1); 163.7; 172.2. FAB-MS:354 ([ M
1] ; calc. for M , 353.18). Anal. calc. for C17H24FN3O4:C 57.78, H 6.85, N 11.89; found:C 57.45, H 6.70, N 11.82.
General Procedure for the Syntheses of Racemic 10, 11, 13, and 15. The starting material (compounds 8, 12,
and 14) was dissolved in dry CH2Cl2 (concentration range:0.025 0.15 m) and placed in a dry sealed tube
equipped with a stir bar. Nucleophile (BuNH2 or PrSH) was added in 10-fold excess. Dry K2CO3 was used as a
base (in equimolar quantity to thiol) for preparation of 10. The color of the reaction solns. became quickly
yellow as product was being formed. The reactions were stirred at r.t. for 10 12 h in a sealed tube. The reaction
temp. for preparation of 15 was 408. At the end of the reaction time, the contents of the reaction soln. were
diluted with 20 ml of CH2Cl2 and extracted sequentially with 1m HCl, brine, and distilled H2O. Org. phase was
dried (MgSO4), filtered, and concentrated under vacuum. Compounds 10 and 11 were directly recrystallized
from hexane/CH2Cl2. Compounds 13 and 15 were chromatographed on silica gel in 1% Et2O/5% Acetone/
CH2Cl2, followed by crystallization from hexane/CH2Cl2. Reported yields are after crystallization.
3,5-Dinitro-4-(propylsulfanyl)-N-(1,2,3,4-tetrahydrophenantren-4-yl)benzamide ((Æ)-10) was obtained
1
from (Æ)-8 as a pale yellow solid:68% yield. M.p. > 1808 (dec.). H-NMR (500 MHz, CDCl3):0.93 ( t, J 7.4,
3 H); 1.54 (tq, J 7.7, 7.3, 2 H); 1.57 (m, 1 H); 1.89 (m, 1 H); 2.02 (m, 2 H); 2.38 (d, J 12.9, 1 H); 2.81 (t, J 7.4,
2 H); 3.02 (m, 2 H); 5.93 (m, 1 H); 6.53 (d, J 7.1, 1 H); 7.25 (d, J 8.4, 1 H); 7.44 (dd, J 7.3, 7.3, 1 H); 7.49
(ddd, J 7.7, 7.7, 1.4, 1 H); 7.74 (d, J 8.4, 1 H); 7.80 (d, J 7.7, 1 H); 7.85 (d, J 8.4, 1 H); 8.15 (s, 2 H).
13C-NMR (125 MHz):13.0; 18.1; 22.8; 29.0; 29.8; 38.5; 44.7; 122.4; 124.8; 125.5; 127.2; 127.9; 128.6; 128.79;
128.80; 131.8; 132.5; 135.2; 136.4; 154.3; 161.1; 169.0. FAB-MS:466.1 ([ M 1] ; calc. for M , 465.14).
4-(Butylamino)-3,5-dinitro-N-(1,2,3,4-tetrahydrophenantren-4-yl)benzamide ((Æ)-11) was obtained from
1
(Æ)-8 as a yellow solid:78% yield. M.p. > 2258 (dec.). H-NMR (400 MHz, CDCl3):0.92 ( t, J 7.3, 3 H); 1.38
(tq, J 7.5, 7.5, 2 H); 1.64 (tt, J 7.3, 7.3, 2 H); 1.95 (m, 2 H); 2.36 (d, J 10.5, 1 H); 5.93 (m, 1 H); 6.45 (d, J
7.6, 1 H); 7.25 (d, J 7.6, 1 H); 7.42 (ddd, J 7.4, 7.4, 1.1, 1 H); 7.47 (ddd, J 7.6, 7.6, 1.5, 1 H); 7.73 (d, J 8.5,
1 H); 7.79 (dd, J 7.8, 1.2, 1 H); 7.87 (d, J 8.3); 8.52 (s, 2 H); 8.58 (br. s, 1 H). 13C-NMR (100 MHz):13.6; 18.1;
19.8; 29.2; 29.9; 31.9; 44.3; 46.3; 119.6; 122.6; 125.3; 127.1; 127.9; 128.5; 128.6; 129.1; 130.6; 131.9; 132.5; 136.2;
136.8; 141.3; 161.8. FAB-MS:463.5 ([ M 1] ; calc. for M ; 462.50).
4-(Butylamino)-N-[1-(diethylcarbamoyl)-3-methylbutyl]-3,5-dinitrobenzamide ((Æ)-13) was obtained from
(Æ)-12 as a yellow solid:53% yield. M.p. 135 137 8. 1H-NMR (400 MHz, CDCl3):0.94 ( d, J 6.1, 6 H); 0.97
(t, J 7.3, 3 H); 1.14 (t, J 7.1, 3 H); 1.30 (td, J 10.9, 2.8, 1 H); 1.44 (t, J 7.1, 3 H); 1.46 (m, 2 H); 1.72 (tt, J
7.4, 7.4, 2 H); 1.86 (dtd, J 10.0, 6.7, 3.5, 1 H); 1.95 (ddd, J 13.8, 12.1, 3.4, 1 H); 2.96 (m, 1 H); 3.05 (m, 2 H);
3.34 (dq, J 14.6, 7.3, 1 H); 3.52 (dq, J 14.6, 7.3, 1 H); 3.97 (dq, J 13.9, 7.0, 1 H); 5.04 (ddd, J 11.1, 8.2, 2.9,
1 H); 8.47 (s, 2 H); 8.58 (t, J 4.5, 1 H); 9.25 (d, J 7.6, 1 H). 13C-NMR (100 MHz):12.7; 13.7; 13.9; 19.9; 21.1;
23.5; 24.9; 31.9; 40.7; 40.9; 42.1; 46.2; 49.0; 118.0; 130.6; 136.4; 140.9; 162.6; 173.1. FAB-MS:452.2 ([ M 1] ;
calc. for M , 451.24). Anal. calc. for C21H33N5O6:C 55.86, H 7.37, N 15.51; found:C 55.53, H 7.41, N 15.13.
4-(Butylamino)-N-[1-(diethylcarbamoyl)-3-methylbutyl]-3-nitrobenzamide ((Æ)-15) was obtained from
1
(Æ)-14 as a pale orange solid:45% yield. M.p. 112 113 8. H-NMR (400 MHz, CDCl3):0.94 ( d, J 6.6, 3 H);
0.98 (t, J 7.3, 3 H); 1.02 (d, J 6.6, 3 H); 1.13 (t, J 7.1, 3 H); 1.31 (t, J 7.2, 3 H); 1.42 (m, 1 H); 1.47
(tq, J 7.5, 7.5, 2 H); 1.73 (m, 3 H); 3.24 (dq, J 13.7, 6.9, 1 H); 3.32 (q, J 6.2, 2 H); 3.44 (q, J 7.2, 2 H); 3.56